| |
Revolutionize your clinical trial! IQVIA experts discuss how the synergy between wearables and eCOA will enhance data collection, patient engagement, regulatory compliance and streamline trial processes. Watch this webinar replay now. .png)
|
|
|
Thursday, July 17, 2025 | 1pm ET / 10am PT In rare disease drug development, where patient populations are small and timelines are accelerated, the right CDMO can make all the difference.
Join us for this deep dive into the key criteria you need to know about when evaluating potential partners for your organization. Don’t miss out on the insights you need to make more confident, informed business decisions. Sign up now! 
|
|
| By Gabrielle Masson Biopharma layoff rounds reported this May hit an all-time high, with 29 RIFs occurring—the most of any month reported over the last four years Fierce Biotech has spent tracking the measure. |
|
|
|
By Angus Liu President Donald Trump has renewed his pledge of drug tariffs to the tune of 200%, but with a grace period of around one year. |
By Gabrielle Masson The FDA has released an "initial batch" of more than 200 complete response letters (CRLs) in efforts to boost transparency. |
By Conor Hale The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo wristband developed by Aktiia. |
|
Thursday, July 22, 2025 | 10am ET / 7am PT Join us to take an exciting look at the forefront of REMS transformation. Learn how leading technology, integrated strategies and operational excellence are redefining what’s possible. Gain the insights you need to reduce complexity, enhance compliance and deliver more value across the REMS lifecycle. Register now. 
|
|
By Kevin Dunleavy Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion for Verona Pharma and its potential blockbuster Ohtuvayre, a first-in-class treatment for chronic obstructive pulmonary disorder (COPD). |
By Gabrielle Masson CSL is consolidating its R&D team in an effort to better position the organization “for long-term success in a rapidly evolving global environment.” |
By Kevin Dunleavy Renee Gala joins a short list of female biopharma chief executives as she is set to take the reins at Jazz Pharmaceuticals, replacing the company’s co-founder Bruce Cozadd, who in December announced his intention to step down, ending his 16-year run as CEO. |
By Kevin Dunleavy Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. The nod is for a new formulation of Coartem, which is also known commercially in come countries as Riamet. |
By Andrea Park As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. |
By James Waldron AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for adeno-associated virus capsids from existing partner JCR Pharmaceuticals to develop genomic medicines. |
By Fraiser Kansteiner After telegraphing plans to build a $2 billion end-to-end cell culture production facility in Holly Springs, North Carolina, in 2021, Fujifilm Biotechnologies will commence commercial operations under the first phase of the site’s buildout later this year. |
By Kevin Dunleavy China's Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy to become the only U.S.-endorsed oral treatment for those with a rare type of non-small cell lung cancer. |
By Darren Incorvaia KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. Now, a new $20 million effort from the Chan Zuckerberg Initiative and Innovative Genomics Institute endeavors to ensure KJ’s treatment isn’t a one-off. |
By Fraiser Kansteiner The FDA has approved sebetralstat under the brand name Ekterly as a new, oral treatment option for acute attacks of hereditary angioedema (HAE) in adults and children ages 12 years and older. The nod came just a few short weeks after the agency missed its June 17 target date originally established for the decision. |
By Andrea Park Amgen's “The Making of a Heart Attack” film premiered last month on A&E, was featured at the Cannes Lions International Festival of Creativity shortly after and is now available to watch on Amgen’s “Attack Heart Disease” website. |
By Fraiser Kansteiner Novo Nordisk has inked a deal with the Tianjin Economic and Technological Development Area to invest roughly $112 million in an upgrade to the quality testing laboratory at its Tianjin, China, manufacturing facility, which has been in operation since 1994. |
Fierce podcasts Don’t miss an episode |
| In this episode of "Podnosis," we explore why some employers are turning to value-based specialty care as a strategy to control costs and improve care quality. |
|
|---|
|
|
|
Now Available On-Demand Legacy GxP systems are holding life sciences back. Learn how to modernize your data infrastructure for better compliance, scalability, and integrity. Explore cloud, AI, and automation strategies in this expert session. Register now to future-proof your records management. 
|
|
Whitepaper This white paper outlines how we apply industry-backed practices and proprietary technologies to proactively safeguard sterility and performance. Sponsored by: Lonza |
Whitepaper Presented by Blue Matter, strategic consultants in the life sciences Sponsored by Blue Matter Consulting |
Whitepaper Learn how to transform your Patient Support Programs into measurable patient-centric initiatives that inform strategic decision making. Sponsored by Herspiegel Consulting |
Executive Summary Biotech innovation doesn’t slow down—and neither should your lab partner. This brief outlines how early scientific engagement, operational transparency, and integrated global lab services help reduce risk, stay on schedule, and deliver results. Whether you're navigating your first trial or scaling a growing pipeline, see how a purpose-built lab model can help you move smarter and faster. Sponsored by: IQVIA Laboratories |
Whitepaper Learn how clinical terminology helps life sciences teams streamline cohorting, reduce bias, and accelerate evidence generation. Sponsored by: IMO Health |
| Sheraton Philadelphia Downtown |
|
| The Lighthouse at Pier 61 in New York City |
|
|
| |
|
